RxDoctor Payments Data

James Carr

Gynecology · Raleigh, NCNPI 1316918238

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.9% of the total across 162 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by Novo Nordisk at 27.5% of the total. Reporting peaked in 2021 at $720 and has fallen 57.7% since, to $305 in 2025.

$2,721in general payments, 2019–2025

Across 162 payments — averaging $16.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$749
  • AbbVie$448
  • Ascend Therapeutics US, LLC$206
  • Mayne Pharma Commercial LLC$163
  • Astellas Pharma US Inc$150
  • Lilly USA, LLC$150
  • plus $855 from 16 others

What the payments were for

  • Food & beverage$2,69199%
  • Education$130%
  • Gifts$171%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,721 in reported general payments places this provider in the 80th percentile of 90 gynecology providers in North Carolina.

See all gynecology providers in North Carolina

Other gynecology in Raleigh

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →